Viatris falls after resolving opioid-related claims for $335 mln

Shares of the drug maker Viatris VTRS.O fall about 3.6% to $7.34, its lowest since 2008

Co says it would pay up to $335 mln over nine years as part of a nationwide settlement to resolve opioid-related claims

VTRS to pay between $27.5 mln and $40 mln annually toward state and local opioid initiatives

Including session moves, stock down about 42% YTD